World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23063
World Ranking
18019
National Ranking
8984

Thomas C. Hamilton publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas C. Hamilton sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 200 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Thomas C. Hamilton D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas C. Hamilton sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Thomas C. Hamilton is affiliated with Fox Chase Cancer Center in the United States. The center is known for its work in cancer research and treatment, though specific details about Hamilton's research focus within this environment are not available.

There are no available records of recent papers, book publications, or detailed main fields and subfields of study linked to Hamilton. Similarly, information on frequent co-authors and publication venues has not been provided.

Without explicit data on research topics, publications, or awards, it is not possible to detail specific areas of scientific contribution or recognition. The absence of such information limits the scope to confirm the scientist's specialization or thematic interests in academic research.

Hamilton is actively working and is not deceased.

Best Publications

  • High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

    Andrew K. Godwin;Alton Meister;Peter J. O'Dwyer;Chin Shiou Huang

  • AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

    Jin Quan Cheng;Andrew K. Godwin;Alfonso Bellacosa;Takahiro Taguchi

  • Platinum resistance: the role of DNA repair pathways.

    Lainie P. Martin;Thomas C. Hamilton;Russell J. Schilder

  • Characterization of a Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3) with Androgen and Estrogen Receptors

    Thomas C. Hamilton;Robert C. Young;Wilma M. McKoy;Karen R. Grotzinger

  • Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

    Thomas C. Hamilton;Margaret A. Winker;Karen G. Louie;Gerald Batist

  • Characterization of a cis-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues

    Brent C. Behrens;Brent C. Behrens;Thomas C. Hamilton;Hidetaka Masuda;Karen R. Grotzinger

  • Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

    Robert F. Ozols;Robert E. Cunnion;Raymond W. Klecker;Thomas C. Hamilton

  • Reversal of adriamycin resistance by verapamil in human ovarian cancer

    Alfred M. Rogan;Thomas C. Hamilton;Robert C. Young;Raymond W. Klecker

  • Advanced epithelial ovarian cancer: 1998 consensus statements.

    J. S. Berek;K. Bertelsen;A. Du Bois;M. F. Brady

  • Radiation Survival Parameters of Antineoplastic Drug-sensitive and -resistant Human Ovarian Cancer Cell Lines and Their Modification by Buthionine Sulfoximine

    Karen G. Louie;Brent C. Behrens;Timothy J. Kinsella;Thomas C. Hamilton

  • Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

    Muthu Selvakumaran;Debra A Pisarcik;Rudi Bao;Anthony T Yeung

  • Focus on epithelial ovarian cancer.

    Robert F. Ozols;Michael A. Bookman;Denise C. Connolly;Mary B. Daly

  • Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer

    Denise C. Connolly;Rudi Bao;Alexander Yu Nikitin;Kasie C. Stephens

  • Increased DNA Repair as a Mechanism of Acquired Resistance to cis-Diamminedichloroplatinum(II) in Human Ovarian Cancer Cell Lines

    Hidetaka Masuda;Robert F. Ozols;Gi-Ming Lai;Antonio Fojo

  • Microscopic Benign and Invasive Malignant Neoplasms and a Cancer-Prone Phenotype in Prophylactic Oophorectomies

    H Salazar;A K Godwin;M B Daly;P B Laub

  • Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.

    Katherine V Ferry;Thomas C Hamilton;Steven W Johnson

  • Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

    J A Green;D T Vistica;R C Young;T C Hamilton

  • The biology of ovarian cancer

    N. Auersperg;M. I. Edelson;S. C. Mok;S. W. Johnson

  • Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.

    Robert F. Ozols;Karen G. Louie;Jacqueline Plowman;Brent C. Behrens

  • Evidence for Altered Regulation of γ-Glutamylcysteine Synthetase Gene Expression among Cisplatin-sensitive and Cisplatin-resistant Human Ovarian Cancer Cell Lines

    Kang-Shen Yao;Andrew K. Godwin;Steven W. Johnson;Robert F. Ozols

Frequent Co-Authors

Robert F. Ozols
Robert F. Ozols Fox Chase Cancer Center
Peter J. O'Dwyer
Peter J. O'Dwyer University of Pennsylvania
Robert C. Young
Robert C. Young Cornell University
Joseph R. Testa
Joseph R. Testa Fox Chase Cancer Center
Andres J. P. Klein-Szanto
Andres J. P. Klein-Szanto Fox Chase Cancer Center
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Henry T. Lynch
Henry T. Lynch Creighton University
Martin Gore
Martin Gore Royal Marsden NHS Foundation Trust
Ira Pastan
Ira Pastan Center for Cancer Research
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens up a variety of online degree options and alternative entry routes. Many students now seek direct entry MSN programs for non-nurses online to transition into advanced nursing roles, even if their undergraduate degree isn’t related to healthcare. These programs are ideal for those looking for a quick, flexible pathway to a master’s in nursing.

If you want to start your nursing education sooner, consider direct admit nursing programs. These options often have less stringent prerequisites and let you begin clinical training earlier. Plus, some top schools now offer admissions without requiring standardized entrance tests such as the TEAS or HESI. Learn more about the requirements at do you have to take the teas test to get into nursing school.

Prefer a non-clinical healthcare career? Accredited medical billing and coding schools that accept fafsa provide solid options, offering essential skills for administrative roles and making education more affordable with financial aid.

Best Scientists Citing Thomas C. Hamilton

Recently Published Articles